1
Background: The risk of colorectal neoplasia in breast cancer survivors is unclear.
2
The pathological examination of material removed from patients with colorectal neoplasia is important.
3
Calcium and vitamin D are important agents for the primary prevention of colorectal neoplasia.
4
The top five biomarkers were selected and recommended for early detection of colorectal neoplasia.
5
Obesity is a well-known risk factor for colorectal neoplasia.
6
There is strong epidemiological and laboratory evidence that vitamin D may be protective against colorectal neoplasia.
7
Our observations provide both clinical and laboratory evidence that muscarinic receptor agonists promote the growth of colorectal neoplasia.
8
Whether these changes are associated with, or may predispose to, an increased risk of colorectal neoplasia needs to be further clarified.
9
The aim was to examine phenotypic expression in colorectal neoplasia and to elucidate changes in such expression through the adenoma-carcinoma sequence.
10
The further accumulation of data with this chemically-induced animal colon carcinogenesis model should provide useful information for understanding colorectal neoplasia in man.
11
The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool.
12
Conclusions: Colorectal neoplasia is as prevalent in Asian Americans and preventive guidelines for colorectal cancer should also be advocated for this ethnic group.
